Evidence map›Paper›PMID 40393455›Full record

ArticleCell reports methods2025

Highly quantitative measurement of differential protein-genome binding with PerCell chromatin sequencing.

Alexi Tallan, Jack Kucinski, Benjamin Sunkel, Cenny Taslim, Stephanie LaHaye, Qi Liu, Jun Qi, Meng Wang, Genevieve C Kendall, Benjamin Z Stanton

Abstract read
In one paragraph

Article in Cell reports methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Alexi TallanNationwide Children's Hospital, Center for Childhood Cancer Research, Columbus, OH, USA; Molecular, Cellular, and Developmental Biology Program, The Ohio State University, Columbus, OH, USA.
Jack KucinskiNationwide Children's Hospital, Center for Childhood Cancer Research, Columbus, OH, USA; Molecular, Cellular, and Developmental Biology Program, The Ohio State University, Columbus, OH, USA.
Benjamin SunkelNationwide Children's Hospital, Center for Childhood Cancer Research, Columbus, OH, USA.
Cenny TaslimNationwide Children's Hospital, Center for Childhood Cancer Research, Columbus, OH, USA.
Stephanie LaHayeNationwide Children's Hospital, Center for Childhood Cancer Research, Columbus, OH, USA.
Qi LiuCancer Biology Department, Dana-Farber Cancer Institute, Boston, MA, USA.
Jun QiCancer Biology Department, Dana-Farber Cancer Institute, Boston, MA, USA.
Meng WangNationwide Children's Hospital, Center for Childhood Cancer Research, Columbus, OH, USA. Electronic address: meng.wang@nationwidechildrens.org.
Genevieve C KendallNationwide Children's Hospital, Center for Childhood Cancer Research, Columbus, OH, USA; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA. Electronic address: genevieve.kendall@nationwidechildrens.org.
Benjamin Z StantonNationwide Children's Hospital, Center for Childhood Cancer Research, Columbus, OH, USA; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA; Department of Biological Chemistry & Pharmacology, The Ohio State University College of Medicine, Columbus, OH, USA. Electronic address: benjamin.stanton@nationwidechildrens.org.

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
Transcriptional Coordination and Gene Regulation by MED12 in the CardiomyocyteR01HL166520 · NHLBI · OHIO STATE UNIVERSITY · PI KEDRYN K BASKIN · 2023 to 2026
$2.3M
Understanding Infantile Rhabdomyosarcoma Biology and Therapeutic TargetsR01CA272872 · NCI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI Genevieve Claire Kendall · 2022 to 2026
$2.1M
Training Program in Basic and Translational Pediatric Oncology ResearchT32CA269052 · NCI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI TIMOTHY P CRIPE · 2022 to 2026
$1.8M
Histone Acetylation Dynamics and Epigenome DuplicationR01GM144601 · NIGMS · OHIO STATE UNIVERSITY · PI PARTHUN, MARK R · 2022 to 2025
$1.6M
NCI NIH HHS P30 CA016058NCI NIH HHS R01 CA272872NCI NIH HHS T32 CA269052NHLBI NIH HHS R01 HL166520NIGMS NIH HHS R01 GM144601
6 · The paper itself

Abstract

Quantitative comparison of ChIP-seq profiling between experimental conditions or samples remains technically challenging for the epigenetics field. Here, we report a strategy combining the use of well-defined cellular spike-in ratios of orthologous species' chromatin and a bioinformatic analysis pipeline to facilitate highly quantitative comparisons of 2D chromatin sequencing across experimental conditions. We find that the PerCell methodology results in efficient and consistent levels of spike-in vs. experimental genomic reads. We demonstrate use of the method and pipeline to enable quantitative, internally normalized chromatin sequencing on zebrafish embryos and human cancer cells. Overall, we propose the PerCell method to enable cross-species comparative epigenomics and promote uniformity of data analyses and sharing across labs.

Indexed as

ChromatinChromatin Immunoprecipitation SequencingGenomeAnimalsCell Line, TumorComputational BiologyEpigenomicsHumansProtein BindingZebrafishChromatinchromatin sequencingCP: molecular biologyCP: systems biologycross-species epigenomicsgenomics normalizationNextflowquantitative epigenomicssarcomatranscription factor

Identifiers

PMID40393455
PMCPMC12272247

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.